Jan. 6, 2020 Price forecast | 2 weeks: -4.26% | 1 month: -8.65% | 3 months: -9.04%


ARWR stock forecast

Our latest prediction for Arrowhead Pharmaceuticals, Inc.'s stock price was made on the Jan. 6, 2020 when the stock price was at 59.44$.

In the short term (2weeks), ARWR's stock price should underperform the market by -4.26%. During that period the price should oscillate between -8.14% and +7.63%.

In the medium term (3months), ARWR's stock price should underperform the market by -9.04%. During that period the price should oscillate between -27.84% and +20.04%.


About Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops medicines that treat intractable diseases by silencing the genes that cause them. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

At the moment the company generates 169M USD in revenues.

On its last earning announcement, the company reported a profit of 0.69$ per share.

The book value per share is 1.15$

Arrowhead Pharmaceuticals, Inc. website


Three months stock forecastJan. 6, 2020


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
169M 100.00% 61M 36.29% 68M 0.69 - - 99M 1.15 173M -12M 161M